Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab
Current Oncology · 2023
DOI: 10.3390/curroncol30100653 ↗Kurz gefasst
Fallbericht in der Zeitschrift Current Oncology, 2023. Verfasst von Beatrice Preti und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medical Oncology, Department of Oncology, Western University, London, ON N6A 3K7, Canada. Hauptthemen laut MEDLINE: Mosaicism, Neoadjuvant Therapy, Colonic Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This research received no external funding..
Abstract (Originalsprache)
We present a fascinating case of a 57-year-old male with a novel mutation in MLH1 (MLH1:c.1288G > T, p.(Glu430*)), who presented with two synchronous colonic tumours, initially deemed unresectable, and experienced a complete pathological response on neoadjuvant pembrolizumab. Extensive genetic testing revealed post-zygotic mosaicism from the novel mutation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Medical Oncology, Department of Oncology, Western University, London, ON N6A 3K7, Canada.
- Division of Molecular Diagnostics, Western University, London, ON N6A 3K7, Canada.
- Department of Pathology and Laboratory Medicine, Western University, London, ON N6A 3K7, Canada.
- Schulich School of Medicine & Dentistry, Western University, London, ON N6A 3K7, Canada.
- Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A1, Canada.
- Department of Surgery, Western University, London, ON N6A 3K7, Canada.
ORCID-Profile: Beatrice Preti, Laila Schenkel
Förderung
- This research received no external funding.
Zitieren
APA
Preti, B., Schenkel, L., Cecchini, M., Romagnoli, T., Sanatani, M. S., French, K., Colquhoun, P., & Vincent, M. D. (2023). Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab. Current Oncology. https://doi.org/10.3390/curroncol30100653
Vancouver
Preti B, Schenkel L, Cecchini M, Romagnoli T, Sanatani MS, French K, et al. Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab. Current Oncology. 2023. doi:10.3390/curroncol30100653
BibTeX
@article{Preti2023,
author = {Preti, Beatrice and Schenkel, Laila and Cecchini, Matthew and Romagnoli, Tommaso and Sanatani, Michael Susmoy and French, Karissa and Colquhoun, Patrick and Vincent, Mark David},
title = {Double Duty: Complete Pathologic Response of Two Colonic Primaries with Mosaicism of a Novel MLH1 Mutation to Neoadjuvant Pembrolizumab},
journal = {Current Oncology},
year = {2023},
doi = {10.3390/curroncol30100653}
}
EUVIMED